Clinical Trial

Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies

Study acronym: HASTA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this single center, interventional cohort study is to evaluate the feasibility of remote electrophysiological cardiotocography (eCTG) monitoring in complicated pregnancies in a home@hospital setting. The primary objective is to assess: • The success rate of the self-administered eCTG measurement The secondary objective is to asses: * Maternal and perinatal outcomes * Patients wellbeing and satisfaction. * Healthcare professionals' (HCPs') satisfaction * Analysis of antenatal costs Participants will: * Self-administer remote eCTG monitoring once daily during admission (or at least twice weekly at the outpatient clinic) * Self-measure their blood pressure, heartrate and temperature * Enter the measurements, symptoms and worries into an application on their telephone. * Answer questionnaires at 3 moments during the study, assessing their wellbeing and satisfaction of the received care and self-administered remote monitoring device.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-27.
Status change: Not Yet Recruiting → Recruiting 2025-09-23
Trial Details
NCT Number NCT06859177
Lead Sponsor Maxima Medical Center
Collaborators: Eindhoven University of Technology
Conditions Pregnancy Related, Remote Monitoring, Feasibility
Enrollment 60 participants
Start Date 2025-03-25
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-26